Skip to content
Riskpilot
← Back to search
Sign in
Get full access
QuantumCell ApS
APS
Active
Advertising protection
CVR 45663205
Nordre Fasanvej 215, 2000
Frederiksberg
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2025 · 1 year old
4 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
QuantumCell ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-2M
-5M
-7M
-9M
-8M
2025
EBITDA
DKK millions
0M
-3M
-6M
-8M
-11M
-9M
2025
Income statement
DKK thousands
Item
2025
Gross profit
-8.169
Staff expenses
-612
EBITDA
-8.781
Depreciation & amort.
-0
EBIT
-8.781
Net financials
-638
Profit before tax
-9.419
Tax
-1.227
Net profit
-8.192
Balance sheet
DKK thousands
Item
2025
Total assets
31.425
Equity
27.589
Long-term debt
0
Short-term debt
3.835
Total debt
3.835
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-878117300.0%
This company
2025
2025
Equity ratio
87.8%
This company
38.2%
Market median
+130% vs market
2025
2025
Return on equity
-29.7%
This company
18.4%
Market median
-261% vs market
2025
2025
Net profit margin (of gross profit)
-819239600.0%
This company
2025
2025
Asset turnover (of gross profit)
-0.26×
This company
2025
2025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-06-07 – 2025-12-31
View
PDF
More on QuantumCell ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
